arrow_back Back to App

Restoring Safeguards for Abortion Drugs: New Rules and Liability

This act aims to reinstate stricter regulations for the abortion drug mifepristone, potentially making it harder to access. It also introduces legal liability for entities that unlawfully provide the drug, causing harm, and bans its importation into the United States.
Key points
Requires the FDA to reinstate the risk evaluation and mitigation strategy (REMS) for mifepristone, identical to the June 2011 strategy, which may restrict its availability.
Establishes legal liability for entities (e.g., telehealth providers, pharmacies) for physical or mental harm to women caused by unlawfully imported or transported mifepristone.
Prohibits the importation of mifepristone into the United States, including mailing it to individuals.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_5646
Sponsor: Rep. Miller, Mary E. [R-IL-15]
Process start date: 2025-09-30
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Restoring Safeguards for Dangerous Abortion Drugs Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_5646.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-30.

What are the main provisions?

Key points include:

  • Requires the FDA to reinstate the risk evaluation and mitigation strategy (REMS) for mifepristone, identical to the June 2011 strategy, which may restrict its availability.
  • Establishes legal liability for entities (e.g., telehealth providers, pharmacies) for physical or mental harm to women caused by unlawfully imported or transported mifepristone.
  • Prohibits the importation of mifepristone into the United States, including mailing it to individuals.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Miller, Mary E. [R-IL-15].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Courts and Law